DM

David A. Moreno

AB Array Biopharma: 5 patents #1 of 68Top 2%
Pfizer: 2 patents #15 of 301Top 5%
LO Loxo Oncology: 1 patents #1 of 13Top 8%
Overall (2023): #17,348 of 537,848Top 4%
7
Patents 2023

Issued Patents 2023

Patent #TitleCo-InventorsDate
11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors Steven W. Andrews, James F. Blake, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +2 more 2023-12-26
11807651 Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more 2023-11-07
11802127 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors Shelley Allen, Patrick Michael DOERNER BARBOUR, James F. Blake, Mark Laurence Boys, Joshua Ryan Dahlke +3 more 2023-10-31
11691973 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors Shelley Allen, Patrick Michael DOERNER BARBOUR, James F. Blake, Sydney Taylor BLANCHE, Mark Laurence Boys +9 more 2023-07-04
11648243 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier +12 more 2023-05-16
11634409 Compounds for the treatment of BRAF-associated diseases and disorders Patrick Barbour, Katie Keaton BROWN, Adam Cook, Erik James Hicken, Dean Russell Kahn +7 more 2023-04-25
11603374 Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors James F. Blake, Donghua Dai, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +6 more 2023-03-14